Go to deals
Healthcare | Private Equity

Science Care has received investment from American Capital Equity

March 2016 — The private shareholders of Science Care have sold the company to American Capital Equity Management LLC for an undisclosed consideration.

Science Care is the world’s largest non-transplant human tissue (NTHT) bank. Headquartered in Phoenix, Arizona, with facilities in California, Colorado, Florida, and Pennsylvania, Science Care provides medical device companies, medical schools and hospitals with NTHT services for training and research purposes. Science Care sources tissue through voluntary whole body donation programs, prepares tissue specimens based on customer demand and specifications, and transports tissue to its domestic and international client base.

Based in Bethesda, Maryland, American Capital Equity Management is a private equity firm specializing in investments in leveraged buy-outs. The firm focuses in middle-market investments in North America. Operating as a subsidiary of American Capital, Ltd, American Capital Equity seeks to invest between US$25–150 million in companies with an EBITDA of US$5–25 million for new platforms but it does not have any minimum for add-ons. The firm seeks to invest in companies with asset-light business models with strong free cash flow conversion. It prefers to take control equity positions but with significant management ownership post close.

Our role in the transaction

Oaklins' team in Los Angeles advised the seller in this transaction.

Parties

Talk to the deal team

Jeremiah Mann

Managing Director
Los Angeles, United States
Oaklins Intrepid

James Freedman

Managing Partner
Los Angeles, United States
Oaklins Intrepid

Related deals

Cibus has acquired Aweta from Standard Investment
Private Equity | Agriculture | Industrial Machinery & Components

Cibus has acquired Aweta from Standard Investment

Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.

Learn more
Comtax has been acquired by Ryan
Private Equity | Business Support Services | TMT

Comtax has been acquired by Ryan

Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.

Learn more
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Healthcare

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Learn more